153 related articles for article (PubMed ID: 31451819)
1. Esterase-sensitive cleavable histone deacetylase inhibitor-coupled hyaluronic acid nanoparticles for boosting anticancer activities against lung adenocarcinoma.
Lee SY; Hong EH; Jeong JY; Cho J; Seo JH; Ko HJ; Cho HJ
Biomater Sci; 2019 Nov; 7(11):4624-4635. PubMed ID: 31451819
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
[TBL] [Abstract][Full Text] [Related]
3. Dually folate/CD44 receptor-targeted self-assembled hyaluronic acid nanoparticles for dual-drug delivery and combination cancer therapy.
Song L; Pan Z; Zhang H; Li Y; Zhang Y; Lin J; Su G; Ye S; Xie L; Li Y; Hou Z
J Mater Chem B; 2017 Sep; 5(33):6835-6846. PubMed ID: 32264333
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.
Xiao B; Han MK; Viennois E; Wang L; Zhang M; Si X; Merlin D
Nanoscale; 2015 Nov; 7(42):17745-55. PubMed ID: 26455329
[TBL] [Abstract][Full Text] [Related]
5. Multi-layered cellulose nanocrystal system for CD44 receptor-positive tumor-targeted anticancer drug delivery.
Seo JH; Lee SY; Hwang C; Yang M; Lee J; Lee SH; Cho HJ
Int J Biol Macromol; 2020 Nov; 162():798-809. PubMed ID: 32585268
[TBL] [Abstract][Full Text] [Related]
6. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration.
Jeong JY; Hong EH; Lee SY; Lee JY; Song JH; Ko SH; Shim JS; Choe S; Kim DD; Ko HJ; Cho HJ
Acta Biomater; 2017 Apr; 53():414-426. PubMed ID: 28216300
[TBL] [Abstract][Full Text] [Related]
7. Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery.
Fang L; Zhang W; Wang Z; Fan X; Cheng Z; Hou X; Chen D
Drug Deliv; 2019 Dec; 26(1):1125-1139. PubMed ID: 31736389
[TBL] [Abstract][Full Text] [Related]
8. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis.
Shi J; Ren Y; Ma J; Luo X; Li J; Wu Y; Gu H; Fu C; Cao Z; Zhang J
J Nanobiotechnology; 2021 Jun; 19(1):188. PubMed ID: 34162396
[TBL] [Abstract][Full Text] [Related]
9. Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer.
Wang B; Zhang W; Zhou X; Liu M; Hou X; Cheng Z; Chen D
Drug Deliv; 2019 Dec; 26(1):1265-1279. PubMed ID: 31777307
[TBL] [Abstract][Full Text] [Related]
10. Copper oxide nanoparticles induce anticancer activity in A549 lung cancer cells by inhibition of histone deacetylase.
Kalaiarasi A; Sankar R; Anusha C; Saravanan K; Aarthy K; Karthic S; Mathuram TL; Ravikumar V
Biotechnol Lett; 2018 Feb; 40(2):249-256. PubMed ID: 29116558
[TBL] [Abstract][Full Text] [Related]
11. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid hydrophilic surface rehabilitating curcumin nanocrystals for targeted breast cancer treatment with prolonged biodistribution.
Ji P; Wang L; Chen Y; Wang S; Wu Z; Qi X
Biomater Sci; 2020 Jan; 8(1):462-472. PubMed ID: 31750450
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria Targeting and Destabilizing Hyaluronic Acid Derivative-Based Nanoparticles for the Delivery of Lapatinib to Triple-Negative Breast Cancer.
Lee SY; Cho HJ
Biomacromolecules; 2019 Feb; 20(2):835-845. PubMed ID: 30566834
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloprotein-triggered, cell penetrating peptide-modified star-shaped nanoparticles for tumor targeting and cancer therapy.
Guo F; Fu Q; Zhou K; Jin C; Wu W; Ji X; Yan Q; Yang Q; Wu D; Li A; Yang G
J Nanobiotechnology; 2020 Mar; 18(1):48. PubMed ID: 32183823
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer.
Zhang W; Xu W; Lan Y; He X; Liu K; Liang Y
Int J Nanomedicine; 2019; 14():5287-5301. PubMed ID: 31406460
[No Abstract] [Full Text] [Related]
16. Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology.
Wu W; Wu J; Fu Q; Jin C; Guo F; Yan Q; Yang Q; Wu D; Yang Y; Yang G
Int J Nanomedicine; 2019; 14():4683-4695. PubMed ID: 31308653
[No Abstract] [Full Text] [Related]
17. pH-responsive hyaluronic acid-based nanoparticles for targeted curcumin delivery and enhanced cancer therapy.
Lai H; Ding X; Ye J; Deng J; Cui S
Colloids Surf B Biointerfaces; 2021 Feb; 198():111455. PubMed ID: 33243547
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma.
Kabary DM; Helmy MW; Elkhodairy KA; Fang JY; Elzoghby AO
Colloids Surf B Biointerfaces; 2018 Sep; 169():183-194. PubMed ID: 29775813
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Characterization of Inhalable Flavonoid Nanoparticle for Lung Cancer Cell Targeting.
Lee WH; Loo CY; Ong HX; Traini D; Young PM; Rohanizadeh R
J Biomed Nanotechnol; 2016 Feb; 12(2):371-86. PubMed ID: 27305771
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
Cui T; Zhang S; Sun H
Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]